Colorado State University spin-out VetDC acquires new drugs to tackle cancer in pets.

VetDC, a veterinarian biotech spin-out of Colorado State University (CSU), has acquired anti-cancer drugs from life sciences firm Pathway Therapeutics. The firm aims to redevelop the drugs, originally designed to fight cancer in humans, to be useful to tackling tumours in animals. The drug, renamed VDC-597, blocks cancer cells from multiplying and growing in an…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.